Related Experiment Video
Updated: Jul 22, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Page Kidney Complicating Kidney Biopsy after Stopping Apixaban: A Physician's Dilemma
Macaulay A C Onuigbo1, Vivek Sharma1, Omotola Balogun1
1Division of Nephrology, Department of Medicine, The Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA.
Abstract:
Page kidney was described by Page, following very elaborate experiments with animal kidneys in 1939, with persistent arterial hypertension from "cellophane perinephritis." Subsequently, it was reported after trauma, from renal cysts and tumors, and from intrarenal hematoma complicating percutaneous kidney biopsy. We describe Page kidney associated with acute kidney injury 26 days after an uncomplicated ultrasound-guided right native kidney biopsy. Patient was on Apixaban, a non-vitamin K antagonist oral anticoagulant (NOAC) for atrial fibrillation which was withheld 3 days before the procedure. It was restarted 3 days after. The evidence-base supporting guidelines and recommendations for the peri-procedural management of the NOACs is inadequate, sparse, and often conflicted. More research is warranted.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Kidney Transplant II: Surgical Procedure
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care

